Iwaoka, Kazuhiro https://orcid.org/0000-0001-8170-5982
Nozaki, Ryota
Takahashi, Kenta
Takahashi, Makoto
Maeda, Tetsuya
Article History
Received: 22 January 2026
Accepted: 21 May 2026
First Online: 8 June 2026
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. The institutional research committee of Iwate Medical University approved this study.
: Written informed consent was obtained from the patient for participation in this study.
: The patient provided written informed consent for publication of this deidentified case report with accompanying images.
: K. Iwaoka, R. Nozaki, and K. Takahashi (Kenta) declare no potential conflicts of interest. M. Takahashi has received funding from Sumitomo Pharma Co., Ltd., FP Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., AbbVie Inc., Ono Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Eisai Co., Ltd., and EA Pharma Co., Ltd. T. Maeda has received grants and honoraria from multiple pharmaceutical companies. All conflicts are unrelated to the submitted work.